Desmoid tumor differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Desmoid_tumor]] | |||
{{CMG}} {{AE}}{{S.M.}}{{Faizan}} | {{CMG}} {{AE}}{{S.M.}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
Revision as of 20:33, 5 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Desmoid tumor must be differentiated from acute hematoma, lymphoma, fibrosarcoma, rhabdomyosarcoma, liposarcoma, leiomyosarcoma, neurofibroma, benign fibrous tumor and primitive neuroectodermal tumor.
Differentiating Desmoid tumor from other Diseases
- Extra-Abdominal Fibromatosis/desmoid tumor must be differentiated from:[1][2][3]
- Fibrosarcoma/fibroblastic sarcoma
- Low-grade fibromyxoid sarcoma[4][5]
- Gardner fibroma[6]
- Intra-Abdominal Fibromatosis must be differentiated from:[7]
- Gastrointestinal stromal tumor (GIST)
- Solitary fibrous tumor (SFT)
- Inflammatory myofibroblastic tumor (IMT)
- Sclerosing mesenteritis
- Retroperitoneal fibrosis due to:[8]
- Idiopathic [Ormond's disease]
- Secondary to certain drugs
- Underlying malignancy such as lymphoma
- Furthermore, desmoid tumors must be differentiated from:
- Acute hematoma
- Lymphoma
- Rhabdomyosarcoma
- Liposarcoma
- Leiomyosarcoma
- Neurofibroma
- Nodular fasciitis
- Hypertrophic scars
- Keloids
- Benign fibrous tumor
- Primitive neuroectodermal tumor
Reference
- ↑ Economou, Athanasios; Pitta, Xanthi; Andreadis, Efstathios; Papapavlou, Leonidas; Chrissidis, Thomas (2011). "Desmoid tumor of the abdominal wall: a case report". Journal of Medical Case Reports. 5 (1): 326. doi:10.1186/1752-1947-5-326. ISSN 1752-1947.
- ↑ Kasper B, Ströbel P, Hohenberger P (2011). "Desmoid tumors: clinical features and treatment options for advanced disease". Oncologist. 16 (5): 682–93. doi:10.1634/theoncologist.2010-0281. PMC 3228186. PMID 21478276.
- ↑ Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.
- ↑ Wu X, Petrovic V, Torode IP, Chow CW (2009). "Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance". Pathology. 41 (2): 155–60. doi:10.1080/00313020802579276. PMID 19152188.
- ↑ Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N; et al. (2010). "Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma". Cancer Genet Cytogenet. 199 (2): 143–6. doi:10.1016/j.cancergencyto.2010.02.011. PMID 20471519.
- ↑ Wehrli BM, Weiss SW, Yandow S, Coffin CM (2001). "Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis". Am J Surg Pathol. 25 (5): 645–51. PMID 11342777.
- ↑ Coffin CM, Hornick JL, Fletcher CD (2007). "Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases". Am J Surg Pathol. 31 (4): 509–20. doi:10.1097/01.pas.0000213393.57322.c7. PMID 17414097.
- ↑ Swartz RD (2009). "Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment". Am J Kidney Dis. 54 (3): 546–53. doi:10.1053/j.ajkd.2009.04.019. PMID 19515472.